4 completed, 1 recruiting, 1 unknown, 1 withdrawn. 2 Phase 1, 2 Phase 3, 2 Phase 4, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Recruiting 1, Withdrawn 1 |
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Liraglutide injection: new trials by email Literature Review of Liraglutide injection trials Research Report on Liraglutide injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery Liraglutide injection, Placebo injection - Delirium, Postoperative | Phase 3 | Recruiting | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 260 | 2024-11-19 | 2024-12-20 |
| Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery Liraglutide injection, Diet and exercise guidelines - Obesity, Weight Loss | Phase 4 | Completed | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 100 | 2023-09-01 | 2026-01-28 |
| POSE2.0 With GLP-1 Agonist for Obesity Management POSE2.0 Endoscopic Gastric Remodeling, Liraglutide injection - Obesity | Not applicable | Unknown | Emirates Health Services (EHS) | 50 | 2023-01-16 | 2023-01-30 |
| Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery Liraglutide injection - Weight Loss, Bariatric Surgery Candidate | Phase 4 | Completed | Hospital Civil Juan I. Menchaca | 37 | 2022-12-18 | 2024-01-18 |
| A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects Liraglutide injection, Liraglutide injection(Victoza®) - Therapeutic Equivalency | Phase 1 | Completed | The Affiliated Hospital of Qingdao University | 32 | 2021-07-16 | 2022-02-07 |
| Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia Liraglutide Injection, Megestrol Acetate 160 MG - Atypical Endometrial Hyperplasia, Obese | Phase 2 / Phase 3 | Withdrawn | Xiaojun Chen | 2021-03-20 | 2024-09-26 | |
| Human Bioequivalence Test of Liraglutide Injection Liraglutide injection, Victoza - Type 2 Diabetes | Phase 1 | Completed | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 28 | 2019-05-21 | 2021-08-31 |
Obesity (3) · Weight Loss (2) · Diabetes Mellitus, Type 2 (1) · Emergence Delirium (1) · Endometrial Hyperplasia (1) · Infertility (1) · Obesity, Morbid (1)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (2) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Emirates Health Services (EHS) (1) · Hospital Civil Juan I. Menchaca (1) · The Affiliated Hospital of Qingdao University (1) · Xiaojun Chen (1)
China (4) · Mexico (1) · United Arab Emirates (1)
Dongjin Wang, PhD,MD (1) · Maryam AlKhatry, MD (1)